ZA96403B - Racemisation - Google Patents

Racemisation

Info

Publication number
ZA96403B
ZA96403B ZA96403A ZA96403A ZA96403B ZA 96403 B ZA96403 B ZA 96403B ZA 96403 A ZA96403 A ZA 96403A ZA 96403 A ZA96403 A ZA 96403A ZA 96403 B ZA96403 B ZA 96403B
Authority
ZA
South Africa
Prior art keywords
compound
alkylated
piperidine
racemisation
racemised
Prior art date
Application number
ZA96403A
Other languages
English (en)
Inventor
Ulrich Conrad Dyer
Martin Woods
Marianne Langston
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of ZA96403B publication Critical patent/ZA96403B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Rolling Contact Bearings (AREA)
  • Optical Head (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA96403A 1995-01-18 1996-01-18 Racemisation ZA96403B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9501071.6A GB9501071D0 (en) 1995-01-18 1995-01-18 Racemisation

Publications (1)

Publication Number Publication Date
ZA96403B true ZA96403B (en) 1997-01-20

Family

ID=10768271

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96403A ZA96403B (en) 1995-01-18 1996-01-18 Racemisation

Country Status (20)

Country Link
EP (1) EP0804417B1 (pl)
JP (1) JP4015696B2 (pl)
KR (1) KR100404390B1 (pl)
CN (1) CN1172912C (pl)
AT (1) ATE242214T1 (pl)
AU (1) AU701221B2 (pl)
BR (1) BR9606821A (pl)
CA (1) CA2208522C (pl)
DE (1) DE69628540T2 (pl)
DK (1) DK0804417T3 (pl)
ES (1) ES2201166T3 (pl)
FI (1) FI117437B (pl)
GB (1) GB9501071D0 (pl)
HU (1) HU227426B1 (pl)
MX (1) MX9705428A (pl)
NO (1) NO308843B1 (pl)
PL (1) PL184091B1 (pl)
PT (1) PT804417E (pl)
WO (1) WO1996022281A1 (pl)
ZA (1) ZA96403B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CN101797221B (zh) 2002-12-13 2013-06-12 杜雷科特公司 包含高粘度液体载体材料的口服递药系统
AU2005287175B2 (en) 2004-09-17 2011-12-01 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
EP2117521B1 (en) 2006-11-03 2012-06-27 Durect Corporation Transdermal delivery systems comprising bupivacaine
JP2011506319A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
JP2016515523A (ja) 2013-03-15 2016-05-30 デュレクト コーポレーション 溶解変動性を低減させるためのレオロジー改質剤を有する組成物
AU2017292791B2 (en) 2016-07-06 2023-05-25 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
CN106187864B (zh) * 2016-07-11 2018-11-23 江苏天和制药有限公司 一种由盐酸布比卡因制备高纯度布比卡因碱的方法
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
EP4479546A2 (en) * 2022-02-16 2024-12-25 Teva Pharmaceuticals International GmbH Processes for preparation of avacopan and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301498A1 (fr) * 1975-02-20 1976-09-17 Maggioni & C Spa Methode pour la racemisation d'une lysine optiquement active

Also Published As

Publication number Publication date
NO973312L (no) 1997-07-17
EP0804417A1 (en) 1997-11-05
AU701221B2 (en) 1999-01-21
BR9606821A (pt) 1997-12-23
WO1996022281A1 (en) 1996-07-25
HUP9901418A2 (hu) 1999-08-30
ES2201166T3 (es) 2004-03-16
CN1172912C (zh) 2004-10-27
AU4394896A (en) 1996-08-07
FI973040A0 (fi) 1997-07-17
PL321378A1 (en) 1997-12-08
DE69628540D1 (de) 2003-07-10
EP0804417B1 (en) 2003-06-04
CA2208522C (en) 2007-03-13
ATE242214T1 (de) 2003-06-15
NO973312D0 (no) 1997-07-17
HUP9901418A3 (en) 2001-01-29
CN1168134A (zh) 1997-12-17
NO308843B1 (no) 2000-11-06
MX9705428A (es) 1997-11-29
JP4015696B2 (ja) 2007-11-28
KR100404390B1 (ko) 2004-01-31
FI117437B (fi) 2006-10-13
FI973040L (fi) 1997-07-17
PT804417E (pt) 2003-09-30
DE69628540T2 (de) 2004-01-08
DK0804417T3 (da) 2003-10-06
CA2208522A1 (en) 1996-07-25
JPH11501905A (ja) 1999-02-16
KR19980701432A (ko) 1998-05-15
HU227426B1 (en) 2011-05-30
PL184091B1 (pl) 2002-08-30
GB9501071D0 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
ZA96403B (en) Racemisation
UA32566C2 (uk) Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану
DE69711632D1 (de) Methode zur dissoziation von biotin komplexen
ATE223383T1 (de) Verfahren zur herstellung von 3-haloalkyl-1h- pyrazole
AU3738597A (en) Molecular model for vla-4 inhibitors
ATE335511T1 (de) Ein verfahren zur inhibierung der komplementaktivierung über einen alternativen weg
MX9803377A (es) Metodo de transmision de informacion y aparato de codificiacion/descodificacion y aparato de codificicacion-multiplexion/descodificacion-desmultiplexion en sistema de transmision de informacion al cual se aplica el metodo de transmision de informacio
ID17698A (id) Proses untuk memproduksi asam l-glutamat dengan fermentasi
ZA961074B (en) Chiral Methylphenyloxazolidinones.
MX9702210A (es) Procesos de racemisacion y transformacion asimetrica usados en la manufactura de levobupuvacaina y sus analogos.
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
DE69637771D1 (de) Eine verbesserte immobilisierte penicillin g acylase
DE69101656D1 (de) Erregerspulensatz, Verfahren zu dessen Herstellung und damit ausgestatteter Micromotor.
EA199800123A1 (ru) Способ получения n-замещенных 3-гидроксипиразолов
TR200002576T2 (tr) 3(R)-ve3(S)-hidroksi-1-metil-4- (2,4,6-trimetoksifenil)- 1,2,3,6-tetrahidro-piridin veya enzimatik enansiyomer ayrışmasına yönelik yöntem
ES2002393A6 (es) Un procedimiento para la preparacion de derivados del acido n-alquil-6-metilergolin-8-carboxilico.
NO308743B1 (no) FremgangsmÕte for fremstilling av N-acetyl- neuraminsyrederivater
DE69611835D1 (de) Verfahren zur herstellung von 1-aryl-1-cyanocyclobutan-derivaten
ATE213782T1 (de) Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate
IT1250734B (it) Procedimento per produrre l-lisina mediante fermentazione
DE59605545D1 (de) Alkoholhaltige instant-getränkemischung, ihre herstellung und verwendung
DE69803979D1 (de) Verfahren zur herstellung von carboxamido-4-azasteroiden
IL150638A0 (en) Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
DE69802171D1 (de) Verfahren zur herstellung von 10,11-dihydro-5h-dibenzo(a,d)cyclohept-5-enen und ihren derivaten
ATE301625T1 (de) Verfahren zur herstellung von 2,6- dimethylnaphthalin